Phenobarbital in Nuclear Receptor Activation: An Update

Area of Science:

• Pharmacology
• Molecular Biology
• Biochemistry

Background:

• Phenobarbital (PB) is an anti-epileptic drug and a model compound for studying xenobiotic-induced drug metabolism.
• PB induces hepatic cytochrome P450 (CYP) enzymes, impacting drug clearance and interactions.
• PB's effects are mediated through nuclear receptors, primarily the constitutive androstane receptor (CAR) and pregnane X receptor (PXR).

Purpose of the Study:

• To review recent advancements in understanding PB-induced transactivation of nuclear receptors, focusing on CAR and PXR.
• To highlight the indirect activation mechanism of CAR by PB via dephosphorylation.

Main Methods:

• Review of existing literature on phenobarbital's effects on nuclear receptors.
• Analysis of signaling pathways involved in PB-mediated CAR and PXR activation.
• Comparison of PB's species-specific effects on PXR.

Main Results:

• PB indirectly activates CAR through dephosphorylation at threonine 38, a conserved site in nuclear receptors.
• PB is a pan-CAR activator but species-specifically activates PXR (human but not mouse).
• PB's role in regulating drug metabolism, drug-drug interactions, energy homeostasis, and cell proliferation is species-dependent.

Conclusions:

• PB has significantly advanced the understanding of nuclear receptor-mediated processes.
• CAR is established as a cell signaling-regulated nuclear receptor beyond ligand-dependent function.
• The mechanisms of PB-induced transactivation of CAR and PXR are crucial for understanding xenobiotic metabolism and drug interactions.